Key result
The prevalence of Type 2 diabetes in Mainland China increased to 5.5% in 2001-2002, and adults with diabetes had a 1.66-fold higher risk of developing cardiovascular disease compared to those with normal fasting glucose.
Hazard Ratio: 1.66 (95% CI 1.33–2.09)
Diabetes-associated CVD risk supports prevention efforts; leaves open current prevalence and risk estimates for updated guidelines.
Global Heart is the official and primary publication of the World Heart Federation, offering a platform for the dissemination of knowledge on research, developments, trends, solutions and public health programmes in the area of cardiovascular disease. Global Heart welcomes research results, points of view and educational material on the prevention, treatment and control of cardiovascular disease with a special focus on low and middle-income countries which are facing the brunt of epidemiological transition.Global Heart strongly encourages authors to adhere to CONSORT, STROBE, STARD, and PRISMA guidelines for reporting of clinical trials, observational studies, diagnostic test accuracy papers, and systematic reviews or meta-analyses. Authors are required for submission to download and complete the appropriate Equator Network checklist: http://www.equator-network.org/.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) conducted a review in Type 2 diabetes and cardiovascular disease. Type 2 diabetes vs. Normal fasting glucose was evaluated on Cardiovascular disease (CHD + Stroke) (HR 1.66, 95% CI 1.33-2.09). The prevalence of Type 2 diabetes in Mainland China increased to 5.5% in 2001-2002, and adults with diabetes had a 1.66-fold higher risk of developing cardiovascular disease compared to those with normal fasting glucose.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: